Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

31,031 signal articles · 127 in last 24h · 158,627 total before filter · latest 2h ago
127last 24h
863last 7d
131● bullish (7d)
82● bearish (7d)
214publishers
AllMacro185Earnings171M&A89Regulatory16Product16Analyst28
✕ clear all filtersticker: NVDASentiment:bullishneutralbearish✓ showing all (incl. clickbait)
The Real Case for Buying Johnson & Johnson (JNJ) Before July 15
24/7 Wall St.78d agobullish
The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

Johnson & Johnson (NYSE:JNJ) is the easiest healthcare name to evaluate on the board heading into its July 15 earnings release, and the setup leaves little to debate. The stock has already told you what it thinks of the fundamentals, rising nearly 25% year to date and nearly 66% over the past year. Yet the ... The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16
24/7 Wall St.78d agobullish
Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16

Intuitive Surgical (NASDAQ:ISRG) looks compelling ahead of its July 16 earnings report, and the setup rarely gets this clean for a category leader trading well below fair value. Shares sit at $413.58, down 26.71% YTD, while the 247 base-case target of $559.79 implies 35.35% upside. Wall Street sits higher still at $563.35, with 22 buy ... Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16

AI Chips Today - AI Advancements Revolutionize Drug Discovery and Cancer Treatment
Simply Wall St.78d agoneutral
AI Chips Today - AI Advancements Revolutionize Drug Discovery and Cancer Treatment

Recent developments in the AI chip sector include a notable collaboration between VERAXA Biotech and Ardigen. This partnership focuses on integrating artificial intelligence into drug discovery processes to enhance VERAXA's BiTAC pipeline, targeting cancer treatments. The AI will aid in selecting synergistic cancer target pairs, potentially improving therapeutic outcomes by reducing toxicity and systemic effects. This initiative highlights the growing role of AI chips in revolutionizing...